GE Healthcare, a unit of GE, will acquire Xcellerex, Inc. for an undisclosed price. The acquisition will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines. According to a GE statement, “The strong strategic fit between the two companies, combined with expanded capabilities in product development and marketing, will offer significant customer benefits.” Xcellerex develops...